EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 126 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $292 | -98.4% | 15 | -97.6% | 0.00% | – |
| Q1 2023 | $17,731 | -23.8% | 625 | -21.5% | 0.00% | – |
| Q4 2022 | $23,267 | +66.2% | 796 | +53.7% | 0.00% | – |
| Q3 2022 | $14,000 | -64.1% | 518 | -41.1% | 0.00% | – |
| Q2 2022 | $39,000 | +34.5% | 879 | +52.3% | 0.00% | – |
| Q1 2022 | $29,000 | -92.6% | 577 | -92.5% | 0.00% | -100.0% |
| Q4 2021 | $394,000 | -9.8% | 7,737 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $437,000 | +22.8% | 7,818 | -6.0% | 0.00% | 0.0% |
| Q2 2021 | $356,000 | -1.4% | 8,318 | -3.6% | 0.00% | 0.0% |
| Q1 2021 | $361,000 | -9.5% | 8,631 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $399,000 | +7.5% | 8,587 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $371,000 | -18.3% | 8,746 | -7.7% | 0.00% | 0.0% |
| Q2 2020 | $454,000 | -4.4% | 9,477 | -8.2% | 0.00% | 0.0% |
| Q1 2020 | $475,000 | -21.9% | 10,319 | +1.9% | 0.00% | -50.0% |
| Q4 2019 | $608,000 | +17.6% | 10,130 | +11.0% | 0.00% | +100.0% |
| Q3 2019 | $517,000 | +12.4% | 9,130 | +10.4% | 0.00% | 0.0% |
| Q2 2019 | $460,000 | +16.2% | 8,269 | +5.4% | 0.00% | 0.0% |
| Q1 2019 | $396,000 | +34.2% | 7,842 | +7.4% | 0.00% | 0.0% |
| Q4 2018 | $295,000 | +32.3% | 7,299 | +127.2% | 0.00% | 0.0% |
| Q3 2018 | $223,000 | +6.7% | 3,212 | +16.1% | 0.00% | 0.0% |
| Q2 2018 | $209,000 | +318.0% | 2,767 | +191.9% | 0.00% | – |
| Q1 2018 | $50,000 | -2.0% | 948 | 0.0% | 0.00% | – |
| Q4 2017 | $51,000 | -10.5% | 948 | 0.0% | 0.00% | – |
| Q3 2017 | $57,000 | -28.8% | 948 | -6.0% | 0.00% | – |
| Q2 2017 | $80,000 | -4.8% | 1,009 | 0.0% | 0.00% | – |
| Q1 2017 | $84,000 | +12.0% | 1,009 | +6.4% | 0.00% | – |
| Q4 2016 | $75,000 | +13.6% | 948 | 0.0% | 0.00% | – |
| Q3 2016 | $66,000 | +100.0% | 948 | +9.8% | 0.00% | – |
| Q2 2016 | $33,000 | -5.7% | 863 | 0.0% | 0.00% | – |
| Q1 2016 | $35,000 | – | 863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |